Yishen Huazhuo decoction (YHD) group	donepezil hydrochloride (DH) group	Alzheimer's Disease Assessment Scale-cognitive subscale (Chinese version) (ADAS-cog) at the follow-up at week 48	-1	-1	YHD  <TAB> 22.03±9.14 <TAB> 20.63±9.37*  <TAB> 18.18±9.79*  <TAB> 19.65±10.62*  <TAB> -3.10±4.55*  <TAB> 1.45±3.74*<NEWLINE> <NEWLINE> <TAB> DH  <TAB> 24.62±8.57 <TAB> 24.01±8.64 <TAB> 22.24±8.89 <TAB> 25.16±11.21 <TAB> -1.22±4.99 <TAB> 4.13±8.62
Yishen Huazhuo decoction (YHD) group	donepezil hydrochloride (DH) group	Alzheimer's Disease Assessment Scale-cognitive subscale (Chinese version) (ADAS-cog) at the follow-up at week 48	18858	18912	* indicates significance between the two study groups.
Yishen Huazhuo decoction (YHD) group	donepezil hydrochloride (DH) group	Alzheimer's Disease Assessment Scale-cognitive subscale (Chinese version) (ADAS-cog) at the follow-up at week 48	10029	10034	table
Yishen Huazhuo decoction (YHD) group	donepezil hydrochloride (DH) group	Alzheimer's Disease Assessment Scale-cognitive subscale (Chinese version) (ADAS-cog) at the follow-up at week 48	19315	19696	The mean scores of ADAS-cog showed a decrease of 3.10±4.55 in YHD group and a decrease of 1.22±4.99 in DH group during the 24 weeks treatment, with statistical significance. The follow-up at week 48 showed that after the treatment, compared with week 24, the scores of ADAS-cog increased 1.45±3.74 in YHD group, but less than the increase of 4.13±8.62 in DH group (p<0.05) (Fig 2).
Yishen Huazhuo decoction (YHD) group	donepezil hydrochloride (DH) group	Alzheimer's Disease Assessment Scale-cognitive subscale (Chinese version) (ADAS-cog) at the follow-up at week 48	-1	-1	<td colspan="1" rowspan="1" align="left"><NEWLINE> <NEWLINE><bold>ADAS-cog</bold><NEWLINE> <NEWLINE></td><td colspan="1" rowspan="1" align="left"></td><td colspan="1" rowspan="1" align="left"></td><td colspan="1" rowspan="1" align="left"></td>
Yishen Huazhuo decoction (YHD) group	donepezil hydrochloride (DH) group	Alzheimer's Disease Assessment Scale-cognitive subscale (Chinese version) (ADAS-cog) at the follow-up at week 48	-1	-1	<th colspan="1" rowspan="1" align="left"></th><th colspan="1" rowspan="1" align="left">Group</th><th colspan="1" rowspan="1" align="left">Baseline</th><th colspan="1" rowspan="1" align="left">12weeks</th><th colspan="1" rowspan="1" align="left">24weeks</th><th colspan="1" rowspan="1" align="left">48weeks</th><th colspan="1" rowspan="1" align="left">Change 24 weeks</th><th colspan="1" rowspan="1" align="left">Change 48 weeks</th>
